Treatment of Amyotrophic Lateral Sclerosis

This publication has 96 references indexed in Scilit:

• Protection from oxidation enhances the survival of cultured mesencephalic neurons
  Experimental Neurology, 1995
• High‐dose dextromethorphan in amyotrophic lateral sclerosis: Phase I safety and pharmacokinetic studies
  Annals of Neurology, 1994
• Antioxidant Mechanism and Protection of Nigral Neurons Against MPP⁺ Toxicity by Deprenyl (Selegiline)
  Annals of the New York Academy of Sciences, 1994
• Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Vitamin E
  Annals of the New York Academy of Sciences, 1992
• Increased binding of3H-L-deprenyI in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Neurosteroids: a new function in the brain
  Biology of the Cell, 1991
• Activation of Glutamate Dehydrogenase by Leucine and Its Nonmetabolizable Analogue in Rat Brain Synaptosomes
  Journal of Neurochemistry, 1990
• The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis
  Annals of Neurology, 1988
• Sex steroids and 5-en-3β-hydroxysteroids in specific regions of the human brain and cranial nerves
  The Journal of Steroid Biochemistry and Molecular Biology, 1986